Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
-
- Clara Montagut
- Medical Oncology Department, Hospital del Mar–CIBERONC, Barcelona, Spain
-
- Guillem Argilés
- Medical Oncology Department, Vall d’Hebron University Hospital, Barcelona, Spain
-
- Fortunato Ciardiello
- Seconda Università degli Studi di Napoli, Naples, Italy
-
- Thomas T. Poulsen
- Symphogen A/S, Ballerup, Denmark
-
- Rodrigo Dienstmann
- Medical Oncology Department, Vall d’Hebron University Hospital, Barcelona, Spain
-
- Michael Kragh
- Symphogen A/S, Ballerup, Denmark
-
- Scott Kopetz
- Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston
-
- Trine Lindsted
- Symphogen A/S, Ballerup, Denmark
-
- Cliff Ding
- Symphogen A/S, Ballerup, Denmark
-
- Joana Vidal
- Medical Oncology Department, Hospital del Mar–CIBERONC, Barcelona, Spain
-
- Jenifer Clausell-Tormos
- Symphogen A/S, Ballerup, Denmark
-
- Giulia Siravegna
- Candiolo Cancer Institute–FPO, IRCCS, Candiolo, Torino, Italy
-
- Francisco J. Sánchez-Martín
- Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain
-
- Klaus Koefoed
- Symphogen A/S, Ballerup, Denmark
-
- Mikkel W. Pedersen
- Symphogen A/S, Ballerup, Denmark
-
- Michael M. Grandal
- Symphogen A/S, Ballerup, Denmark
-
- Mikhail Dvorkin
- BHI of Omsk Region “Clinical Oncology Dispensary,” Omsk, Russia
-
- Lucjan Wyrwicz
- Centrum Onkologii-Instytut im. M. Sklodowskiej Curie, Warsaw, Poland
-
- Ana Rovira
- Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain
-
- Antonio Cubillo
- Centro Integral Oncologico Clara Campa, Madrid, Spain
-
- Ramon Salazar
- Institut Català d’Oncologia, Institut d’Investigació biomèdica de Bellvitge, CIBERONC, Barcelona, Spain
-
- Françoise Desseigne
- Consultation d'Oncologie Génétique, Centre de Lutte Contre le Cancer Leon Berard, Lyon, France
-
- Cristina Nadal
- Hospital Clinic of Barcelona, University of Barcelona, Spain
-
- Joan Albanell
- Medical Oncology Department, Hospital del Mar–CIBERONC, Barcelona, Spain
-
- Vittorina Zagonel
- Medical Oncology Unit 1, Istituto Oncologico Veneto, IRCCS, Padova, Italy
-
- Salvatore Siena
- Grande Ospedale Metropolitano Niguarda and Università degli Studi di Milano, Milano, Italy
-
- Guglielmo Fumi
- Azienda Ospedaliera S. Maria Di Terni, Terni, Italy
-
- Giuseppe Rospo
- Candiolo Cancer Institute–FPO, IRCCS, Candiolo, Torino, Italy
-
- Paul Nadler
- Symphogen A/S, Ballerup, Denmark
-
- Ivan D. Horak
- Symphogen A/S, Ballerup, Denmark
-
- Alberto Bardelli
- Candiolo Cancer Institute–FPO, IRCCS, Candiolo, Torino, Italy
-
- Josep Tabernero
- Medical Oncology Department, Vall d’Hebron University Hospital, Barcelona, Spain
Bibliographic Information
- Other Title
-
- A Phase 2 Randomized Clinical Trial
Journal
-
- JAMA Oncology
-
JAMA Oncology 4 (4), e175245-, 2018-04-12
American Medical Association (AMA)
- Tweet
Details 詳細情報について
-
- CRID
- 1364233270187167872
-
- ISSN
- 23742437
-
- Data Source
-
- Crossref